Serum apolipoproteins and apolipoprotein-defined lipoprotein subclasses: a hypothesis-generating prospective study of cardiovascular events in T1D

High density lipoprotein with apolipoprotein C-III is associated with carotid intima-media thickness among generally healthy individuals

(2018) Rain Yamamoto et al.   ATHEROSCLEROSIS

Burden of cardiovascular risk factors and disease among patients with type 1 diabetes: results of the Australian National Diabetes Audit (ANDA)

(2018) Anthony Pease et al.   Cardiovascular Diabetology

Apolipoprotein-defined lipoprotein subclasses, serum apolipoproteins, and carotid intima-media thickness in T1D

(2018) Arpita Basu et al.   JOURNAL OF LIPID RESEARCH

High‐Density Lipoprotein Subspecies Defined by Apolipoprotein C‐III and Subclinical Atherosclerosis Measures: MESA (The Multi‐Ethnic Study of Atherosclerosis)

(2018) Sarah A. Aroner et al.   Journal of the American Heart Association

High-Density Lipoprotein Subspecies Defined by Presence of Apolipoprotein C-III and Incident Coronary Heart Disease in Four Cohorts

(2017) Majken K. Jensen et al.   CIRCULATION

Expression of apolipoprotein C-III in McA-RH7777 cells enhances VLDL assembly and secretion under lipid-rich conditions

(2017) Meenakshi Sundaram et al.   JOURNAL OF LIPID RESEARCH

Nuclear magnetic resonance-determined lipoprotein subclasses and carotid intima-media thickness in type 1 diabetes

(2016) Arpita Basu et al.   ATHEROSCLEROSIS

Risk Factors for Cardiovascular Disease in Type 1 Diabetes

(2016)   DIABETES

Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT/EDIC Study 30-Year Follow-up

(2016)   DIABETES CARE

Circulating Apolipoprotein E Concentration and Cardiovascular Disease Risk: Meta-analysis of Results from Three Studies

(2016) Reecha Sofat et al.   PLOS MEDICINE

The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and meta-analysis

(2015) Moritz C. Wyler von Ballmoos et al.   Journal of Clinical Lipidology

Effect of Intensive Diabetes Therapy on the Progression of Diabetic Retinopathy in Patients With Type 1 Diabetes: 18 Years of Follow-up in the DCCT/EDIC

(2014)   DIABETES

Oxidized LDL and AGE-LDL in circulating immune complexes strongly predict progression of carotid artery IMT in type 1 diabetes

(2013) Kelly J. Hunt et al.   ATHEROSCLEROSIS

Update on Cardiovascular Outcomes at 30 Years of the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study

(2013) John M. Lachin et al.   DIABETES CARE

Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness

(2013) Fei Huang et al.   PLoS One

Serum Apolipoproteins Are Associated With Systemic and Retinal Microvascular Function in People With Diabetes

(2012) M. B. Sasongko et al.   DIABETES

High Concentrations of AGE-LDL and Oxidized LDL in Circulating Immune Complexes Are Associated With Progression of Retinopathy in Type 1 Diabetes

(2012) M. F. Lopes-Virella et al.   DIABETES CARE

Progression of Carotid Artery Intima-Media Thickness During 12 Years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study

(2011) J. F. Polak et al.   DIABETES

Oxidized LDL immune complexes and coronary artery calcification in type 1 diabetes

(2010) Maria F. Lopes-Virella et al.   ATHEROSCLEROSIS

Apolipoprotein C-III and the Metabolic Basis for Hypertriglyceridemia and the Dense Low-Density Lipoprotein Phenotype

(2010) Chunyu Zheng et al.   CIRCULATION

Association of Apolipoprotein B with Incident Type 2 Diabetes in an Aboriginal Canadian Population

(2010) S. H. Ley et al.   CLINICAL CHEMISTRY

Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

(2008) John J.P. Kastelein et al.   CIRCULATION

Apolipoprotein C-III: understanding an emerging cardiovascular risk factor

(2008) Esther M. M. Ooi et al.   CLINICAL SCIENCE

Statin Therapy Alters the Relationship Between Apolipoprotein B and Low-Density Lipoprotein Cholesterol and Non–High-Density Lipoprotein Cholesterol Targets in High-Risk Patients

(2008) Christie M. Ballantyne et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY